GLP1RA improve blood pressure and reduce CV event risk, likely through central and peripheral autonomic regulation, increased natriuresis, and the presence of these genes in CV tissues (e.g., endothelial cells, vascular smooth muscle cells, resistance arteries) 53
SGP started out by selling building rights, and is now concluding joint-ventures with private developers using a new company (SGP Immobilier) to maximise land-value capture (Aveline et Maulat, 2024)
Tesamorelin adds preferential visceral fat targeting to the equation
I couldnt help but wonder: Could these drugs do more than just help my patient to lose weight
They can advise on the safest timing and may suggest a gradual dose reduction or a brief pause of 12 weeks maximum, followed by a structured restart protocol